A cryopreserved, amniotic placental tissue allograft
RHEO™ is a flowable amniotic placental tissue allograft. RHEO™ is aseptically processed using a proprietary minimally manipulated approach that retains the extracellular matrix and 3D collagen structure of its scaffold. It is combined with amniotic fluid, then cryopreserved to maintain the viability of the intercellular messengers. The allograft provides a natural collagen scaffold to support replacement by endogenous tissue.1 RHEO™ is intended for homologous use in the repair, replacement, reconstruction, or augmentation of human tissue.
VEGF: 36.6± 3.2 pg per 1-mil
bFGF: 802± 34 pg per 1-mil
PDGF-BB: 38.7± 2.8 pg per 1-ml
IL-1ra: 13,015± 58 pg 1-mil
1 Olczyk P, Mencner Ł, Komosinska-Vassev K. The role of the extracellular matrix components in cutaneous wound healing. Biomed Res Int. 2014;2014:747584. doi:10.1155/2014/747584